<?xml version="1.0" encoding="UTF-8"?>
<p id="par0065">From time immemorial, infectious diseases have ravaged mankind. Only 100 years ago, tuberculosis (TB) was still one of the top three leading causes of death in the USA 
 <xref rid="bib0005" ref-type="bibr">[1]</xref>. Fortunately, science advanced dramatically during the 20th century, changing the ways in which our society treats infectious diseases. Current preventative vaccines and drugs are catered to treat long-lasting and/or chronic infections or infectious diseases that recur annually or on a regular basis, such as HIV, TB, hepatitis C, influenza, and so on. However, the major viral disease outbreaks that have plagued society over the past two decades do not follow this pattern. In fact, they have shown that the scientific community is not adequately prepared to offer or rapidly develop effective treatments when an outbreak happens 
 <xref rid="bib0010" ref-type="bibr">[2]</xref>. As a consequence, all countries have to adopt nontherapeutic measures to slow the progression of the epidemic and ‘flatten the curve’ to limit the burden of the disease on the healthcare system and allow better support to severely ill patients 
 <xref rid="bib0015" ref-type="bibr">[3]</xref>.
</p>
